C07K 14/57527
Calcitonin gene related peptide
Official title: {Calcitonin gene related peptide}
C07K14/57527 (Calcitonin gene related peptide) appears on 40 US grants and 47 published applications in this corpus.
Search patents in C07K- Granted patents
- 40
- Published applications
- 47
- Assignees
- 28
- Inventors
- 116
- Latest grant
- 8 Oct 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 2 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 4 |
| 2012 | 1 | 2 |
| 2013 | 1 | 4 |
| 2014 | 3 | 3 |
| 2015 | 3 | 1 |
| 2016 | 1 | 3 |
| 2017 | 0 | 3 |
| 2018 | 3 | 2 |
| 2019 | 3 | 3 |
| 2020 | 2 | 5 |
| 2021 | 3 | 2 |
| 2022 | 3 | 4 |
| 2023 | 1 | 1 |
| 2024 | 3 | 2 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Peptide analogs8 Oct 2024US 12,110,318 B2Adepthera LLC
- Use of CGRP receptor antagonists in neuroprotection and neurological disorders1 Oct 2024US 12,103,951 B2
- Protein signatures for distinguishing between bacterial and viral infections23 Jul 2024US 12,044,681 B2MeMed Diagnostics Ltd.
- In vivo protein N-acylation3 Oct 2023US 11,773,378 B2Duke University
- Methods and compositions for treating a microbial infection2 Aug 2022US 11,400,136 B2Children's Medical Center Corporation
- Cgrp antagonist compositions and methods of use thereof10 Sep 2026US 2026/0263524 A1University of Miami
- Peptide analogs15 May 2025US 2025/0154219 A1Adepthera LLC
- Protein signatures for distinguishing between bacterial and viral infections19 Dec 2024US 2024/0418716 A1MeMed Diagnostics Ltd.
- Compositions for improved delivery of cgrp inhibitors29 Feb 2024US 2024/0066028 A1Pfizer Ireland Pharmaceuticals
- Use of cgrp receptor antagonists in neuroprotection and neurological disorders6 Jul 2023US 2023/0212248 A1
Most cited
By later US patents
- Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals34US 4,530,838 AThe Salk Institute for Biological Studies · 1985
- CGRP antibodies25US 9,073,991 B2Eli Lilly and Company · 2015
- Oligopeptides and intermediates and processes for their manufacture24US 4,720,483 ACiba-Geigy Corporation · 1988
- Calcitonin gene related peptide analogs with amino acid subdstituents at the penultimate position 3616US 4,697,002 A1987
- CGRP peptide antagonists and conjugates16US 8,168,592 B2Amgen Inc. · 2012